In a report released on August 28, Kate McShane from Goldman Sachs maintained a Buy rating on Petco Health and Wellness Company, with a price target of $5.14.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Kate McShane’s rating is based on Petco Health and Wellness Company’s better-than-expected adjusted earnings per share for the second quarter of 2025, which came in at $0.07, surpassing both Goldman Sachs and consensus estimates. Despite a slight decline in net revenue and comparable sales, the company’s adjusted EBITDA exceeded expectations, indicating strong operational performance.
Moreover, the management’s decision to raise the full-year earnings outlook, particularly the adjusted EBITDA forecast, reflects confidence in the company’s future financial performance. This positive outlook, alongside the introduction of guidance for the third quarter, supports the Buy rating as it suggests potential for continued growth and profitability in the upcoming quarters.
In another report released on August 29, RBC Capital also maintained a Buy rating on the stock with a $4.00 price target.
WOOF’s price has also changed moderately for the past six months – from $2.690 to $3.230, which is a 20.07% increase.